Desmoda FDA Approval: First Oral Liquid Desmopressin for Central Diabetes Insipidus
Introduction The recent Desmoda fda approval represents a major advancement in endocrine therapeutics, particularly in the treatment of central diabetes insipidus (CDI). DESMODA (desmopressin acetate) oral solution is now officially approved by the U.S. Food and Drug Administration for managing CDI in both adults and pediatric patients. What makes this regulatory milestone particularly significant is …